FCGH meets License to Heal

License to HealAn interesting initiative from the Netherlands has come to our attention. It’s called License to Heal, and its manifesto touches upon many key elements of the Framework Convention on Global Health (FCGH), the proposed international treaty presently gathering support across a wide array of civil society organizations. Both License to Heal and the FCGH see having a legal framework to assure universal access to medicines as imperative, and as a ‘do-able’ challenge. It would seem that these two NGOs should meet, share, and agree to collaborate — for access to medicines for all.

Below is some information from the License to Heal website. It’s worth having a visit. They also can be followed on twitter,  although reading some Dutch may be useful.
———————–

“We need to design a sustainable business model to ensure medication is available for all, for a fair price!”. This is a statement from the manifesto License to Heal that is written by eight political youth parties in the Netherlands.

Together they ask their national government to make legislation that directs pharmaceutical companies to be transparent about their prices and determine their prices conform a limited profit margin. A wonderful initiative in which the political youth parties showed leadership by setting aside their political differences and come to a shared vision on this important topic.

The cooperating Political Youth Organisations are convinced that drugs and other medical products should be accessible to everyone. We feel supported in this matter by several international treaties, in which the universal right to health has been recorded. To realise general accessibility, all stakeholders in the development of medicine need to take their social responsibility. Since stakeholders cannot or will not take this responsibility in the current system, the government needs to set a framework.

Read moreFCGH meets License to Heal

Access to Medicines Now!

Access to MedicinesACCESS TO MEDICINES IS A BASIC HUMAN RIGHT

On International Women’s Day (Wednesday 8th March 2017) this letter was issued by the Tobeka Daki Campaign for Access to Trastuzumab to the Human Rights Council, as they convened a panel discussion on access to medicines in the context of the right to health.
———————-

Zeid Ra’ad Al Hussein,
United Nations High Commissioner for Human Rights
Geneva, Switzerland

Dear High Commissioner Zeid Ra’ad Al Hussein,

We are writing to you from the Tobeka Daki Campaign for Access to Trastuzumab in South Africa on the occasion of International Women’s Day to highlight the gross injustice faced by women across the globe in many low and middle income countries who cannot access lifesaving cancer treatments due to the exorbitant pricing of the pharmaceutical industry.

The Tobeka Daki Campaign launched a month ago on 7th February 2017. The campaign is in loving memory of a fearless activist who lead the struggle to ensure access to breast cancer treatment for women in South Africa. Despite being prescribed trastuzumab, a WHO essential medicine for the treatment of HER2+ breast cancer, Tobeka was never able to access the treatment due to its high cost. In South Africa, the annual price charged by Swiss multinational company Roche in the private sector is around US$ 38,365. The few public facilities which can access trastuzumab do so at a lower price of around US$ 15,735 per year. But, health economists have shown that a year’s worth of trastuzumab can be produced and sold for only US$ 240, a price that includes a 50% increase above the cost of production for profit.

Read moreAccess to Medicines Now!